G2MH Research Participation & COVID-19 Survey

June 25, 2020

G2MH, an international group of scientists and healthcare providers, many of whom are supported by the US National Institutes of Health (NIH), is interested in learning about why families and persons affected by chromosome differences may or may not participate in research studies. In addition, given the current COVID-19 pandemic, G2MH is also hoping to learn about how families are coping during this difficult time.

Survey

Related Posts

November 15th – International 15q Day

November 15th – International 15q Day

November 15th - International 15q Day Together with Angelman Syndrome Foundation and the Foundation for Prader-Willi Research, we are raising awareness of the similarities between Dup15q Syndrome, Angelman and Prader-Willi Syndromes. Prader-Willi, Angelman and Dup15q...

2020 – Rare Champion of Hope Award Nominee

2020 – Rare Champion of Hope Award Nominee

Congratulations to Vanessa Vogel-Farley who has been nominated for the Global Genes 2020 Rare Champion of Hope Awards. These individuals, organizations and collaborations are the groundbreakers, leaders and advocates who inspire and catalyze change in rare disease....

  In 2020 we have worked hard on developing and expanding committees and programs that will help provide guidance and resources for families affected by Dup15q Syndrome. As we turn the corner into 2021, we are expanding our research and the search for targeted...